| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antifungal combination treatment: a future perspective
|
Fohrer, Cécile
|
|
2006
|
27 |
S1 |
p. 25-30
6 p.
|
artikel
|
| 2 |
Antifungal drug resistance: limited data, dramatic impact?
|
Rogers, Thomas R.
|
|
2006
|
27 |
S1 |
p. 7-11
5 p.
|
artikel
|
| 3 |
Antifungals and renal safety—getting the balance right
|
Saliba, Faouzi
|
|
2006
|
27 |
S1 |
p. 21-24
4 p.
|
artikel
|
| 4 |
Editorial Board
|
|
|
2006
|
27 |
S1 |
p. CO2-
1 p.
|
artikel
|
| 5 |
Managing the challenges of invasive fungal infections
|
Herbrecht, Raoul
|
|
2006
|
27 |
S1 |
p. 1-2
2 p.
|
artikel
|
| 6 |
Potential role of aerosolized amphotericin B formulations in the prevention and adjunctive treatment of invasive fungal infections
|
Drew, Richard
|
|
2006
|
27 |
S1 |
p. 36-44
9 p.
|
artikel
|
| 7 |
Selection criteria for antifungals: the right patients and the right reasons
|
Chandrasekar, Pranatharthi
|
|
2006
|
27 |
S1 |
p. 17-20
4 p.
|
artikel
|
| 8 |
The changing epidemiology of invasive fungal infections: new threats
|
Maschmeyer, Georg
|
|
2006
|
27 |
S1 |
p. 3-6
4 p.
|
artikel
|
| 9 |
The experience is CLEAR®
|
Chandrasekar, Pranatharthi
|
|
2006
|
27 |
S1 |
p. 31-35
5 p.
|
artikel
|
| 10 |
What is the current and future status of conventional amphotericin B?
|
Kleinberg, Michael
|
|
2006
|
27 |
S1 |
p. 12-16
5 p.
|
artikel
|
Tijdschrift beschrijving